-
1Academic Journal
المؤلفون: Wheatley, Duncan A., Berardi, Rossana, Climent Duran, Miguel A., Tomiak, Anna, Greystoke, Alastair P., Joshua, Anthony M., Arkenau, Hendrik-Tobias, Géczi, Lajos, Corbacho, Javier Garciá, Paz-Ares, Luis G., Hussain, Syed A., Petruželka, Lubos, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C., Michelon, Elisabete, Murphy, Danielle A., Mwewa, Sandrine, Cesari, Rossano, Doger de Spéville, Bernard
المساهمون: Wheatley, Duncan A., Berardi, Rossana, Climent Duran, Miguel A., Tomiak, Anna, Greystoke, Alastair P., Joshua, Anthony M., Arkenau, Hendrik-Tobia, Géczi, Lajo, Corbacho, Javier Garciá, Paz-Ares, Luis G., Hussain, Syed A., Petruželka, Lubo, Delmonte, Angelo, Chappey, Colombe, Masters, Joanna C., Michelon, Elisabete, Murphy, Danielle A., Mwewa, Sandrine, Cesari, Rossano, Doger de Spéville, Bernard
Relation: info:eu-repo/semantics/altIdentifier/pmid/38669053; info:eu-repo/semantics/altIdentifier/wos/WOS:001321759000003; volume:4; issue:6; firstpage:1609; lastpage:1619; numberofpages:11; journal:CANCER RESEARCH COMMUNICATIONS; https://hdl.handle.net/11566/333019
-
2Academic Journal
المؤلفون: Paz Ares, Luis G., Provencio Pulla, Mariano
المساهمون: UAM. Departamento de Medicina
مصطلحات موضوعية: PD-1 checkpoint inhibitor, immunotherapy, first-line, metastatic non–small cell lung cancer, CTLA-4, Medicina
وصف الملف: application/pdf
Relation: Journal of Thoracic Oncology; https://doi.org/10.1016/j.jtho.2021.09.010; Journal of Thoracic Oncology 17.2 (2022): 289-308; 1556-1380 (online); 1556-0864 (print); http://hdl.handle.net/10486/711613; 289; 308; 17
-
3Academic Journal
المؤلفون: Peters, Solange, Paz-Ares, Luis G., Reck, Martin, Carbone, David P., Brahmer, Julie R., Borghaei, Hossein, Lu, Shun, O'Byrne, Kenneth J., John, Thomas, Ciuleanu, Tudor Eliade, Schenker, Michael, Bernabe Caro, Reyes, Nishio, Makoto, Cobo, Manuel, Lee, Jong Seok, Zurawski, Bogdan, Pluzanski, Adam, Aoyama, Takekazu, Tschaika, Marina, Devas, Vipul, Grootendorst, Diederik J., Ramalingam, Suresh S.
المصدر: Journal of Thoracic Oncology
مصطلحات موضوعية: Immunotherapy, Ipilimumab, Nivolumab, Non–small cell lung cancer, PD-L1
Relation: Peters, Solange, Paz-Ares, Luis G., Reck, Martin, Carbone, David P., Brahmer, Julie R., Borghaei, Hossein, Lu, Shun, O'Byrne, Kenneth J., John, Thomas, Ciuleanu, Tudor Eliade, Schenker, Michael, Bernabe Caro, Reyes, Nishio, Makoto, Cobo, Manuel, Lee, Jong Seok, Zurawski, Bogdan, Pluzanski, Adam, Aoyama, Takekazu, Tschaika, Marina, Devas, Vipul, Grootendorst, Diederik J., & Ramalingam, Suresh S. (2025) Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab–Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis. Journal of Thoracic Oncology, 20(1), pp. 94-108.; https://eprints.qut.edu.au/253941/; Faculty of Health
الاتاحة: https://eprints.qut.edu.au/253941/
-
4Academic Journal
المؤلفون: Le, Xiuning, Paz-Ares, Luis G., van Meerbeeck, Jan, Viteri, Santiago, Galvez, Carlos Cabrera, Smit, Egbert F., Garassino, Marina, Veillon, Remi, Baz, David Vicente, Pradera, Jose Fuentes, Sereno, Maria, Kozuki, Toshiyuki, Kim, Young-Chul, Yoo, Seung Soo, Han, Ji-Youn, Kang, Jin-Hyoung, Son, Choon-Hee, Choi, Yoon Ji, Stroh, Christopher, Juraeva, Dilafruz, Vioix, Helene, Bruns, Rolf, Otto, Gordon, Johne, Andreas, Paik, Paul K.
المصدر: Cell reports medicine ; 2666-3791
مصطلحات موضوعية: Biology, Human medicine
Relation: info:eu-repo/semantics/altIdentifier/isi/001124453600001
-
5Academic Journal
المؤلفون: Paz-Ares, Luis G., Ciuleanu, Tudor-Eliade, Cobo, Manuel, Bennouna, Jaafar, Schenker, Michael, Cheng, Ying, Juan-Vidal, Oscar, Mizutani, Hideaki, Lingua, Alejo, Reyes-Cosmelli, Felipe, Reinmuth, Niels, Menezes, Juliana, Jassem, Jacek, Protsenko, Svetlana, Richardet, Eduardo, Felip, Enriqueta, Feeney, Kynan, Zurawski, Bogdan, Alexandru, Aurelia, de la Mora Jimenez, Emmanuel, Dakhil, Shaker, Lu, Shun, Reck, Martin, John, Thomas, Hu, Nan, Zhang, Xiaoqing, Sylvester, Judi, Eccles, Laura J., Grootendorst, Diederik J., Balli, David, Neely, Jaclyn, Carbone, David P.
المصدر: Journal of Thoracic Oncology ; volume 18, issue 2, page 204-222 ; ISSN 1556-0864
-
6Academic Journal
المؤلفون: Le, Xiuning, Paz-Ares, Luis G., Van Meerbeeck, Jan, Viteri, Santiago, Galvez, Carlos Cabrera, Smit, Egbert F., Garassino, Marina, Veillon, Remi, Baz, David Vicente, Pradera, Jose Fuentes, Sereno, María, Kozuki, Toshiyuki, Kim, Young-Chul, Yoo, Seung Soo, Han, Ji-Youn, Kang, Jin-Hyoung, Son, Choon-Hee, Choi, Yoon Ji, Stroh, Christopher, Juraeva, Dilafruz, Vioix, Helene, Bruns, Rolf, Otto, Gordon, Johne, Andreas, Paik, Paul K.
المصدر: Cell Reports Medicine ; volume 4, issue 11, page 101280 ; ISSN 2666-3791
-
7Academic Journal
المؤلفون: Paz-Ares, Luis G., Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong-Seok, Gainor, Justin F., Otterson, Gregory A., Audigier-Valette, Clarisse, Ready, Neal, Schenker, Michael, Linardou, Helena, Caro, Reyes Bernabe, Provencio, Mariano, Zurawski, Bogdan, Lee, Ki Hyeong, Kim, Sang-We, Caserta, Claudia, Ramalingam, Suresh S., Spigel, David R., Brahmer, Julie R., Reck, Martin, O’Byrne, Kenneth J., Girard, Nicolas, Popat, Sanjay, Peters, Solange, Memaj, Arteid, Nathan, Faith, Aanur, Nivedita, Borghaei, Hossein
المصدر: Journal of Thoracic Oncology ; volume 18, issue 1, page 79-92 ; ISSN 1556-0864
-
8Academic Journal
المؤلفون: Reck, Martin, Ciuleanu, Tudor-Eliade, Lee, Jong-Seok, Schenker, Michael, Zurawski, Bogdan, Kim, Sang-We, Mahave, Mauricio, Alexandru, Aurelia, Peters, Solange, Pluzanski, Adam, Caro, Reyes Bernabe, Linardou, Helena, Burgers, Jacobus A., Nishio, Makoto, Martinez-Marti, Alex, Azuma, Koichi, Axelrod, Rita, Paz-Ares, Luis G., Ramalingam, Suresh S., Borghaei, Hossein, O’Byrne, Kenneth J., Li, Li, Bushong, Judith, Gupta, Ravi G., Grootendorst, Diederik J., Eccles, Laura J., Brahmer, Julie R.
المساهمون: Bristol-Myers Squibb Company
المصدر: Journal of Thoracic Oncology ; volume 18, issue 8, page 1055-1069 ; ISSN 1556-0864
-
9Academic Journal
المؤلفون: Paz-Ares, Luis G., Ramalingam, Suresh S., Ciuleanu, Tudor Eliade, Lee, Jong Seok, Urban, Laszlo, Caro, Reyes Bernabe, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Audigier-Valette, Clarisse, Burgers, Jacobus A., Pluzanski, Adam, Sangha, Randeep, Gallardo, Carlos, Takeda, Masayuki, Linardou, Helena, Lupinacci, Lorena, Lee, Ki Hyeong, Caserta, Claudia, Provencio, Mariano, Carcereny, Enric, Otterson, Gregory A., Schenker, Michael, Zurawski, Bogdan, Alexandru, Aurelia, Vergnenegre, Alain, Raimbourg, Judith, Feeney, Kynan, Kim, Sang We, Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D., Memaj, Arteid, Nathan, Faith Ellen, Bushong, Judith, Tran, Phuong, Brahmer, Julie R., Reck, Martin
المصدر: Journal of Thoracic Oncology
مصطلحات موضوعية: CTLA-4, First-line, Immunotherapy, Metastatic non–small cell lung cancer, PD-1 checkpoint inhibitor
وصف الملف: application/pdf
Relation: https://eprints.qut.edu.au/233054/1/111970939.pdf; Paz-Ares, Luis G., Ramalingam, Suresh S., Ciuleanu, Tudor Eliade, Lee, Jong Seok, Urban, Laszlo, Caro, Reyes Bernabe, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Audigier-Valette, Clarisse, Burgers, Jacobus A., Pluzanski, Adam, Sangha, Randeep, Gallardo, Carlos, Takeda, Masayuki, Linardou, Helena, Lupinacci, Lorena, Lee, Ki Hyeong, Caserta, Claudia, Provencio, Mariano, Carcereny, Enric, Otterson, Gregory A., Schenker, Michael, Zurawski, Bogdan, Alexandru, Aurelia, Vergnenegre, Alain, Raimbourg, Judith, Feeney, Kynan, Kim, Sang We, Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D., Memaj, Arteid, Nathan, Faith Ellen, Bushong, Judith, Tran, Phuong, Brahmer, Julie R., & Reck, Martin (2022) First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial. Journal of Thoracic Oncology, 17(2), pp. 289-308.; https://eprints.qut.edu.au/233054/; Centre for Genomics and Personalised Health; Faculty of Health; School of Biomedical Sciences
الاتاحة: https://eprints.qut.edu.au/233054/
-
10Academic Journal
المؤلفون: Paz-Ares, Luis G., Ramalingam, Suresh S., Ciuleanu, Tudor-Eliade, Lee, Jong-Seok, Urban, Laszlo, Caro, Reyes Bernabe, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Audigier-Valette, Clarisse, Burgers, Jacobus A., Pluzanski, Adam, Sangha, Randeep, Gallardo, Carlos, Takeda, Masayuki, Linardou, Helena, Lupinacci, Lorena, Lee, Ki Hyeong, Caserta, Claudia, Provencio, Mariano, Carcereny, Enric, Otterson, Gregory A., Schenker, Michael, Zurawski, Bogdan, Alexandru, Aurelia, Vergnenegre, Alain, Raimbourg, Judith, Feeney, Kynan, Kim, Sang-We, Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D., Memaj, Arteid, Nathan, Faith Ellen, Bushong, Judith, Tran, Phuong, Brahmer, Julie R., Reck, Martin
المصدر: Journal of Thoracic Oncology ; volume 17, issue 2, page 289-308 ; ISSN 1556-0864
-
11Academic Journal
المؤلفون: Gainor, Justin F., Curigliano, Giuseppe, Kim, Dong-Wan, Lee, Dae Ho, Besse, Benjamin, Baik, Christina S., Doebele, Robert C., Cassier, Philippe A., Lopes, Gilberto, Tan, Daniel S. W., Garralda, Elena, Paz-Ares, Luis G., Cho, Byoung Chul, Gadgeel, Shirish M., Thomas, Michael, Liu, Stephen, V, Taylor, Matthew H., Mansfield, Aaron S., Zhu, Viola W., Clifford, Corinne, Zhang, Hui, Palmer, Michael, Green, Jennifer, Turner, Christopher D., Subbiah, Vivek
المساهمون: 김동완, Kim, Dong-Wan
مصطلحات موضوعية: TARGETING RET, DOCETAXEL, NIVOLUMAB
Relation: The Lancet Oncology, Vol.22 No.7, pp.959-969; 138096; https://hdl.handle.net/10371/179098; 000668269600041; 2-s2.0-85108806193
الاتاحة: https://hdl.handle.net/10371/179098
https://doi.org/10.1016/S1470-2045(21)00247-3 -
12Academic Journal
المؤلفون: Paz-Ares, Luis G, Ramalingam, Suresh S, Ciuleanu, Tudor-Eliade, Lee, Jong-Seok, Urban, Laszlo, Caro, Reyes Bernabe, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Audigier-Valette, Clarisse, Burgers, Jacobus A, Pluzanski, Adam, Sangha, Randeep, Gallardo, Carlos, Takeda, Masayuki, Linardou, Helena, Lupinacci, Lorena, Lee, Ki Hyeong, Caserta, Claudia, Provencio, Mariano, Carcereny, Enric, Otterson, Gregory A, Schenker, Michael, Zurawski, Bogdan, Alexandru, Aurelia, Vergnenegre, Alain, Raimbourg, Judith, Feeney, Kynan, Kim, Sang-We, Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D, Memaj, Arteid, Nathan, Faith Ellen, Bushong, Judith, Tran, Phuong, Brahmer, Julie R, Reck, Martin
مصطلحات موضوعية: CTLA-4, First-line, Immunotherapy, Metastatic non–small cell lung cancer, PD-1 checkpoint inhibitor, Adult, Antineoplastic Combined Chemotherapy Protocols, Humans, Ipilimumab, Lung Neoplasms, Neoplasm Recurrence, Local, Nivolumab
-
13Academic Journal
المؤلفون: Brahmer, Julie R., Lee, Jong Seok, Ciuleanu, Tudor Eliade, Bernabe Caro, Reyes, Nishio, Makoto, Urban, Laszlo, Audigier-Valette, Clarisse, Lupinacci, Lorena, Sangha, Randeep, Pluzanski, Adam, Burgers, Jacobus, Mahave, Mauricio, Ahmed, Samreen, Schoenfeld, Adam J., Paz-Ares, Luis G., Reck, Martin, Borghaei, Hossein, O'Byrne, Kenneth J., Gupta, Ravi G., Bushong, Judith, Li, Li, Blum, Steven I., Eccles, Laura J., Ramalingam, Suresh S.
المصدر: Journal of Clinical Oncology
Relation: Brahmer, Julie R., Lee, Jong Seok, Ciuleanu, Tudor Eliade, Bernabe Caro, Reyes, Nishio, Makoto, Urban, Laszlo, Audigier-Valette, Clarisse, Lupinacci, Lorena, Sangha, Randeep, Pluzanski, Adam, Burgers, Jacobus, Mahave, Mauricio, Ahmed, Samreen, Schoenfeld, Adam J., Paz-Ares, Luis G., Reck, Martin, Borghaei, Hossein, O'Byrne, Kenneth J., Gupta, Ravi G., Bushong, Judith, Li, Li, Blum, Steven I., Eccles, Laura J., & Ramalingam, Suresh S. (2023) Five-Year Survival Outcomes with Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227. Journal of Clinical Oncology, 41(6), pp. 1200-1212.; https://eprints.qut.edu.au/244567/; Centre for Genomics and Personalised Health; Faculty of Health; School of Biomedical Sciences
الاتاحة: https://eprints.qut.edu.au/244567/
-
14Academic Journal
المؤلفون: Reck, Martin, Ciuleanu, Tudor Eliade, Lee, Jong Seok, Schenker, Michael, Zurawski, Bogdan, Kim, Sang We, Mahave, Mauricio, Alexandru, Aurelia, Peters, Solange, Pluzanski, Adam, Caro, Reyes Bernabe, Linardou, Helena, Burgers, Jacobus A., Nishio, Makoto, Martinez-Marti, Alex, Azuma, Koichi, Axelrod, Rita, Paz-Ares, Luis G., Ramalingam, Suresh S., Borghaei, Hossein, O'Byrne, Kenneth J., Li, Li, Bushong, Judith, Gupta, Ravi G., Grootendorst, Diederik J., Eccles, Laura J., Brahmer, Julie R.
المصدر: Journal of Thoracic Oncology
مصطلحات موضوعية: Brain metastases, Intracranial outcomes, Ipilimumab, Nivolumab, NSCLC
Relation: Reck, Martin, Ciuleanu, Tudor Eliade, Lee, Jong Seok, Schenker, Michael, Zurawski, Bogdan, Kim, Sang We, Mahave, Mauricio, Alexandru, Aurelia, Peters, Solange, Pluzanski, Adam, Caro, Reyes Bernabe, Linardou, Helena, Burgers, Jacobus A., Nishio, Makoto, Martinez-Marti, Alex, Azuma, Koichi, Axelrod, Rita, Paz-Ares, Luis G., Ramalingam, Suresh S., Borghaei, Hossein, O'Byrne, Kenneth J., Li, Li, Bushong, Judith, Gupta, Ravi G., Grootendorst, Diederik J., Eccles, Laura J., & Brahmer, Julie R. (2023) Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. Journal of Thoracic Oncology, 18(8), pp. 1055-1069.; https://eprints.qut.edu.au/244565/; Centre for Genomics and Personalised Health; Faculty of Health; School of Biomedical Sciences
الاتاحة: https://eprints.qut.edu.au/244565/
-
15Academic Journal
المؤلفون: Reuss, Joshua E, Gandhi, Sunil G, Spigel, David R, Janne, Pasi A, Paz-Ares, Luis G, Gadgeel, Shirish M, Patel, Jyoti D, Passiglia, Francesco, Spira, Alexander I, Edelman, Martin J, Blumenschein, George R
المصدر: Hematology/Oncology Meeting Abstracts
مصطلحات موضوعية: adagrasib avutometinib bevacizumab creatine kinase defactinib everolimus focal adhesion kinase immune checkpoint inhibitor sotorasib adult adverse drug reaction aged anemia antineoplastic activity cancer inhibition conference abstract diarrhea drug combination drug therapy female human lung adenocarcinoma major clinical study male multicenter study non small cell lung cancer open study oral drug administration phase 2 clinical trial rash side effect systemic therapy, Hematology
Relation: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/176; http://sfxhosted.exlibrisgroup.com/hfhs?sid=EMBASE&issn=15277755&id=doi:10.1200%2Fjco.2023.41.16_suppl.9100&atitle=RAMP+202%3A+A+phase+2+study+of+avutometinib+%28VS-6766%29+%C2%B1+defactinib,+in+patients+with+advanced+KRAS+G12V+mutant+non-small+cell+lung+cancer+%28NSCLC%29&stitle=J.+Clin.+Oncol.&title=Journal+of+Clinical+Oncology&volume=41&issue=16&spage=9100&epage=&aulast=Reuss&aufirst=Joshua+E.&auinit=J.E.&aufull=Reuss+J.E.&coden=&isbn=&pages=9100-&date=2023&auinit1=J&auinitm=E
الاتاحة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/176
http://sfxhosted.exlibrisgroup.com/hfhs?sid=EMBASE&issn=15277755&id=doi:10.1200%2Fjco.2023.41.16_suppl.9100&atitle=RAMP+202%3A+A+phase+2+study+of+avutometinib+%28VS-6766%29+%C2%B1+defactinib,+in+patients+with+advanced+KRAS+G12V+mutant+non-small+cell+lung+cancer+%28NSCLC%29&stitle=J.+Clin.+Oncol.&title=Journal+of+Clinical+Oncology&volume=41&issue=16&spage=9100&epage=&aulast=Reuss&aufirst=Joshua+E.&auinit=J.E.&aufull=Reuss+J.E.&coden=&isbn=&pages=9100-&date=2023&auinit1=J&auinitm=E -
16Academic Journal
المؤلفون: Paz-Ares, Luis G., Ciuleanu, Tudor Eliade, Pluzanski, Adam, Lee, Jong Seok, Gainor, Justin F., Otterson, Gregory A., Audigier-Valette, Clarisse, Ready, Neal, Schenker, Michael, Linardou, Helena, Caro, Reyes Bernabe, Provencio, Mariano, Zurawski, Bogdan, Lee, Ki Hyeong, Kim, Sang We, Caserta, Claudia, Ramalingam, Suresh S., Spigel, David R., Brahmer, Julie R., Reck, Martin, O'Byrne, Kenneth J., Girard, Nicolas, Popat, Sanjay, Peters, Solange, Memaj, Arteid, Nathan, Faith, Aanur, Nivedita, Borghaei, Hossein
المصدر: Journal of Thoracic Oncology
مصطلحات موضوعية: Immune-mediated adverse events, Ipilimumab, Nivolumab, NSCLC, Safety
Relation: Paz-Ares, Luis G., Ciuleanu, Tudor Eliade, Pluzanski, Adam, Lee, Jong Seok, Gainor, Justin F., Otterson, Gregory A., Audigier-Valette, Clarisse, Ready, Neal, Schenker, Michael, Linardou, Helena, Caro, Reyes Bernabe, Provencio, Mariano, Zurawski, Bogdan, Lee, Ki Hyeong, Kim, Sang We, Caserta, Claudia, Ramalingam, Suresh S., Spigel, David R., Brahmer, Julie R., Reck, Martin, O'Byrne, Kenneth J., Girard, Nicolas, Popat, Sanjay, Peters, Solange, Memaj, Arteid, Nathan, Faith, Aanur, Nivedita, & Borghaei, Hossein (2023) Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817. Journal of Thoracic Oncology, 18(1), pp. 79-92.; https://eprints.qut.edu.au/243394/; Centre for Genomics and Personalised Health; Faculty of Health; School of Biomedical Sciences
الاتاحة: https://eprints.qut.edu.au/243394/
-
17Academic Journal
المؤلفون: Paz-Ares, Luis G., Carbone, David P.
المصدر: Journal of Thoracic Oncology ; volume 18, issue 9, page e102-e103 ; ISSN 1556-0864
-
18Conference
المؤلفون: Ozgurogiu, Mustafa, Goldman, Jonathan W., Chen, Yuanbin, Garassino, Marina Chiara, Medic, Nenad, Mann, Helen, Paz-Ares, Luis G.
Relation: Journal of Clinical Oncology; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; https://hdl.handle.net/20.500.12831/9009; 40; 16; WOS:000863680302173
-
19Academic Journal
المؤلفون: Kim, Edward S, Kelly, Karen, Paz-Ares, Luis G, Garrido, Pilar, Jalal, Shadia, Mahadevan, Daruka, Gutierrez, Martin, Provencio, Mariano, Schaefer, Eric, Shaheen, Monte, Johnston, Erica L, Turner, P Kellie, Kambhampati, Siva Rama Prasad, Beckmann, Richard, Hossain, Anwar, John, William J, Goldman, Jonathan W
المصدر: Clinical Cancer Research, vol 24, iss 22
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Lung, Clinical Trials and Supportive Activities, Digestive Diseases, Cancer, Lung Cancer, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Adult, Aged, 80 and over, Aminopyridines, Antineoplastic Combined Chemotherapy Protocols, Benzimidazoles, Carcinoma, Non-Small-Cell Lung, Drug Administration Schedule, Female, Humans, Lung Neoplasms, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Staging, Treatment Outcome
Time: 5543 - 5551
وصف الملف: application/pdf
Relation: qt44q4x16z; https://escholarship.org/uc/item/44q4x16z
-
20Conference
المؤلفون: Gettinger, Scott N., Huber, Rudolf M., Kim, Dong-Wan, Bazhenova, Lyudmila, Holmskov Hansen, Karin, Tiseo, Marcello, Langer, Corey J., Paz-Ares, Luis G., West, Howard, Reckamp, Karen L., Weiss, Glen J., Smit, Egbert F., Hochmair, Maximilian, Kim, Sang-We, Ahn, Myung-Ju, Kim, Edward S., Groen, Harry J.M., Pye, Joanna, Vranceanu, Florin, Camidge, D. Ross
المصدر: Gettinger , S N , Huber , R M , Kim , D-W , Bazhenova , L , Holmskov Hansen , K , Tiseo , M , Langer , C J , Paz-Ares , L G , West , H , Reckamp , K L , Weiss , G J , Smit , E F , Hochmair , M , Kim , S-W , Ahn , M-J , Kim , E S , Groen , H J M , Pye , J , Vranceanu , F & Camidge , D R 2021 , ' Brigatinib (BRG) in ALK+ crizotinib ....